Skip to search formSkip to main contentSkip to account menu

AZD0865

National Institutes of Health

Related topics

Related topics

3 relations

Broader (2)

ImidazolesPyridines
linaprazan

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
Evaluation of the use of Classical Nucleation Theory for predicting intestinal crystalline precipitation of two weakly basic BSC class II drugs.
2014
2014
Predictors of either rapid healing or refractory reflux oesophagitis during treatment with potent acid suppression
Little is known regarding patient characteristics that influence the speed of reflux oesophagitis (RO) healing. 
2013
2013
Impact of regurgitation on health-related quality of life in gastro-oesophageal reflux disease before and after short-term potent acid suppression therapy
Objective Limited data exist on the impact of regurgitation on health-related quality of life (HRQOL) in gastro-oesophageal… 
Highly Cited
2012
Highly Cited
2012
Regurgitation is less responsive to acid suppression than heartburn in patients with gastroesophageal reflux disease.
2012
2012
Concomitant Symptoms Itemized in the Reflux Disease Questionnaire Are Associated With Attenuated Heartburn Response to Acid Suppression
OBJECTIVES:The Reflux Disease Questionnaire (RDQ) contains six symptom items for diagnosing and gauging gastroesophageal reflux… 
2011
2011
Co-administration of a nanosuspension of a poorly soluble basic compound and a solution of a proton pump inhibitor—the importance of gastrointestinal pH and solubility for the in vivo exposure
In Sigfridsson et al. (2011, Drug Dev Ind Pharm, 37:243–251), there was no difference in plasma concentration of BA99 when… 
Highly Cited
2008
Highly Cited
2008
A Randomized, Comparative Trial of a Potassium-Competitive Acid Blocker (AZD0865) and Esomeprazole for the Treatment of Patients With Nonerosive Reflux Disease
OBJECTIVES:AZD0865 is a gastric acid-suppressing agent that has a rapid onset of action and long duration of effect. This double… 
2007
2007
Mechanism of action of AZD0865, a K+-competitive inhibitor of gastric H+,K+-ATPase.
Review
2006
Review
2006
Acid Suppression Therapy: Where Do We Go from Here?
The dramatic success of pharmacological acid suppression in healing peptic ulcers and managing patients with gastroesophageal… 
2006
2006
Characteristics of the K+-competitive H+,K+-ATPase inhibitor AZD0865 in isolated rat gastric glands.
The gastric H+,K+-ATPase of the parietal cell is responsible for acid secretion in the stomach and is the main target in the… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)